Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2005
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277640 Pyrimidine derivatives for treatment of hyperproliferative disorders
12/15/2005US20050277638 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005US20050277630 Antibacterial agents
12/15/2005US20050277628 Substituted thiophene carboxamides
12/15/2005DE102004026732A1 m-Phenylendiamin-Kupplerkomponenten m-phenylenediamine coupler components
12/15/2005DE102004024773A1 Substituierte 2,5-Diaminomethyl-1H-pyrrole Substituted 2,5-diaminomethyl-1H-pyrroles
12/15/2005CA2568341A1 Leptomycin compounds
12/15/2005CA2567832A1 Quinazoline derivatives as erbb receptor tyrosine kinases
12/15/2005CA2566531A1 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005CA2566187A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2565280A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2563831A1 Monocyclic heterocycles as kinase inhibitors
12/14/2005EP1604989A1 DPP-IV inhibitors
12/14/2005EP1604988A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1603905A1 Vanilloid receptor ligands and their use in treatments
12/14/2005EP1603904A1 Antibacterial 1, 3- oxazolidin -2- one derivatives
12/14/2005EP1603903A1 Antibacterial oxalidinones
12/14/2005EP1603897A1 Pyrazole compounds useful in the treatment of inflammation
12/14/2005EP1603893A1 Ep4 receptor antagonists
12/14/2005EP1603887A1 Hiv replication inhibiting pyrimidines and triazines
12/14/2005EP1603884A2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
12/14/2005EP1603879A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/14/2005EP1603572A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
12/14/2005EP1603570A2 Aminoheteroaryl compounds as protein kinase inhibitors
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1311296B1 Solution of an oxazolidinone antibiotic drug
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005EP0506830B1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1231762C Method for directly identifying candidate compound
12/14/2005CN1231482C Processes for the preparation of thiazolidinedione derivatives and intermediates
12/14/2005CN1231476C Substd. pyridine herbicides
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231215C (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/14/2005CA2471177A1 Novel combi-molecules having egfr and dna targeting properties
12/13/2005US6974869 Piperizinones as modulators of chemokine receptor activity
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/12/2005WO2005121110A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/08/2005WO2005117242A1 Method and installation means for installing an electrical machine
12/08/2005WO2005116029A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005116024A1 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
12/08/2005WO2005116023A1 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
12/08/2005WO2005116022A1 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
12/08/2005WO2005116021A1 3-[4-(6-{4,5-dihydroisoxazol-3-yl}pyridin-3-yl)-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
12/08/2005WO2005116020A1 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors
12/08/2005WO2005116019A1 Thioether derivatives, their manufacture and use as pharmaceutical agents
12/08/2005WO2005116018A1 TYROSINE DERIVATIVES SUBSTITUTED BYALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005116017A1 Process for the preparation of aryl substituted oxazolidinones as intermediates for antibacterial agents
12/08/2005WO2005116016A1 Compounds and compositions as ppar modulators
12/08/2005WO2005116014A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
12/08/2005WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof
12/08/2005WO2005116009A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
12/08/2005WO2005116002A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/08/2005WO2005115998A1 TYROSINE DERIVATIVES SUBSTITUTED BY ALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005115991A1 Anti-cytokine heterocyclic compounds
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115985A1 Aminopyridine derivatives as selective dopamine d3 agonists
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115398A2 Hiv integrase inhibitors
12/08/2005WO2005115392A2 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors
12/08/2005WO2005077932A3 Chemokine receptor antagonists
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272793 Pyrazole compounds and uses related thereto
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272788 Indoles having anti-diabetic activity
12/08/2005US20050272784 Inhibitors of bacterial Type III protein secretion systems
12/08/2005US20050272779 2-[5-(3-Methoxy-phenyl)-[1,2,4]oxadiazol-3-ylmethylsulfanyl]-1H-benzoimidazole, for example; useful for the inhibition of transient lower esophageal sphincter relaxations and thus for treatment of gastro-esophageal reflux disorder
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272740 Benzimidazole derivatives
12/08/2005US20050272731 stereospecific saponification of a racemic ester using a lipase enzyme, then reduction of a beta -keto amide and esters, to form chemical intermediate for 16-membered macrolide rings used as antitumor agents
12/08/2005US20050272729 Cytotoxic agents comprising taxanes and their therapeutic use
12/08/2005US20050272728 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/08/2005US20050272727 As antitumor and anticancer agents
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272704 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/08/2005US20050272702 Coupling process for generating reactive boron-containing derivatives of N-substituted pyrrole-2-carbonitriles to produce biaryls
12/08/2005DE102004024454A1 Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New Enantiomerically pure beta agonists, to processes for their preparation and their use as medicaments
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005CA2567929A1 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
12/08/2005CA2567457A1 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections
12/08/2005CA2567454A1 3-[4-(6-{4,5-dihydroisoxazol-3-yl}pyridin-3-yl)-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
12/08/2005CA2566963A1 3-[4-{6-substituted alkanoyl pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2565486A1 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005CA2565263A1 2-styryl-4-oxazole-methanol-ethers and their use as tyrosine kinase inhibitors
1 ... 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 ... 647